Key Takeaways
- DVC Partners has acquired a majority stake in Kimitec, a developer of biological solutions for agriculture.
- Kimitec develops and manufactures natural alternatives for crop nutrition and protection, with applications spanning plant, animal and human health.
- The company runs a vertically integrated platform covering in-house research and development, manufacturing and global distribution.
- Kimitec’s technology relies on a proprietary AI model and one of Europe’s largest biotechnology hubs focused on biostimulants and biocontrol.
- The investment is intended to accelerate Kimitec’s innovation capacity, expand its international footprint and strengthen its position in sustainable agriculture.
DVC Partners Takes Majority Stake in Kimitec
DVC Partners has acquired a majority stake in Kimitec, a company that develops biological solutions for agriculture. Kimitec produces natural alternatives for crop nutrition and protection, with applications that extend across plant, animal and human health. Both companies confirmed the transaction, which marks DVC Partners’ entry as majority shareholder.
Kimitec’s Integrated Biotech Platform
Kimitec operates what it describes as a fully integrated platform, combining proprietary research and development, manufacturing, and a global distribution network. Its technology relies on a proprietary artificial intelligence model and draws on what the company calls one of Europe’s largest biotechnology hubs specializing in biostimulants and biocontrol solutions.
Kimitec’s Next Phase of Growth
With backing from DVC Partners, Kimitec said it plans to accelerate its innovation capacity, strengthen its international presence and consolidate its position in sustainable agriculture. In a statement on LinkedIn, Kimitec described the investment as an endorsement of a project that has spent years applying science, innovation and biotechnology to agriculture, and said its mission of turning innovation into value for the industry remains unchanged under the new ownership structure.
DVC Partners Investment Rationale
DVC Partners said the transaction reflects its broader strategy of backing companies with differentiated technologies, high growth potential and international reach. The firm confirmed the deal in a separate announcement, describing Kimitec as a leading provider of biological agricultural solutions entering a new phase of development under its ownership.
